Gurugram, July 15: FCL , the dermatologist-led skincare brand, has announced the nationwide online availability of its Biomimetic Exosome Skincare Range, marking the first time the range is being made widely accessible to consumers beyond dermatology clinics. Previously offered primarily through dermatology clinics, the range is now available on the FCL website and leading e-commerce platforms, enabling consumers across India to experience one of the brand’s most advanced skincare innovations.
The expansion comes at a time when Indian consumers are increasingly seeking science-backed, dermatologist-developed skincare that delivers visible results. As awareness around advanced skincare ingredients continues to grow, consumers are also becoming more receptive to technologies that enhance the performance of clinically proven actives rather than simply introducing new ingredients.
Biomimetic exosomes are plant-derived, laboratory-engineered microscopic carriers that mimic the skin’s natural communication system. Rather than acting as skincare ingredients themselves, they help deliver active ingredients deeper into the skin, improving their absorption and overall performance. By enhancing ingredient delivery, biomimetic exosome technology improves the effectiveness of formulations, helping address concerns such as pigmentation, early signs of ageing and skin barrier repair more efficiently than conventional topical delivery systems.
Positioned within the professional skincare category, the FCL Biomimetic Exosome Range combines advanced biomimetic exosome technology with clinically recognised active ingredients in dermatologist-developed formulations. Each product is backed by extensive formulation research, sophisticated delivery technology and premium active ingredients designed to maximise ingredient efficacy. This combination of advanced science, specialised formulation expertise and intelligent delivery systems reflects the range’s positioning within the premium skincare segment.
Commenting on the expanded availability, Ms. Shaily Mehrotra, CEO & Co-founder, Fixderma & FCL, said:
“Consumers today are looking beyond skincare trends and placing greater trust in products backed by credible science. Biomimetic exosome technology represents one of the most exciting advancements in topical skincare because it enhances how active ingredients are delivered and perform on the skin. By expanding the availability of this range beyond dermatology clinics, we are making next-generation skincare innovations more accessible while continuing our commitment to bringing globally relevant, dermatologist-developed solutions to consumers across India.”
The FCL Biomimetic Exosome Skincare Range includes:
FCL Exo Radiance Serum
Designed for dull, uneven and pigmented skin, the serum combines biomimetic exosomes with DDS Cysteamine, Niacinamide and Ceramide Complex to visibly reduce pigmentation, improve skin radiance and reinforce the skin barrier.
FCL Exo Renew Serum
Formulated for early and visible signs of ageing, the serum combines biomimetic exosomes with DDS Retinal, Argireline Peptide and Hyaluronic Acid to help improve skin firmness, reduce the appearance of fine lines and provide long-lasting hydration.
FCL Exo Restore Overnight Crème
An overnight moisturiser formulated with biomimetic exosomes, Ceramide Complex, Panthenol, Hyaluronic Acid and Willow Bark Extract to deeply hydrate the skin, strengthen the skin barrier and support overnight skin recovery.
Availability: The FCL Biomimetic Exosome Skincare Range is now available on the FCL website, leading e-commerce platforms and through dermatology clinics across India.
With its expanded online availability, FCL continues to strengthen its omnichannel presence while making dermatologist-developed skincare innovations more accessible to consumers nationwide. The launch reinforces the brand’s commitment to bringing globally relevant skincare technologies to India through evidence-based formulations that deliver healthier, stronger and more resilient skin.